ABILIFY – The evidence base for the prescribing of aripiprazole in maintenance treatment of bipolar disorder is limited to a single trial, sponsored by the manufacturer of aripiprazole
Public release date: 3-May-2011 Limitations of evidence base for prescribing aripiprazole in maintenance therapy of bipolar disorder - The evidence base for the prescribing of aripiprazole in maintenance treatment of…
You must be logged in to post a comment.